REFERENCES
- Al-Awadi F, Khattar M, Gumaa K (1985): On the mechanism of the hypoglycaemic effect of a plant extract. Diabetolo-gia 28: 432–434.
- Alton GG, Jones L, Pietz DE (1975): Laboratory Techniques in Brucellosis, Serological Methods, 2nd ed. World Health Organization, Geneva, pp. 64–131.
- Aqel M (1995). The relaxing effects of the volatile oil of Nigella sativa seeds on vascular smooth muscles. Dirasat 19: 91–100.
- Bancraft TD, Stevens A (1990): Theory and Practical of His-tological Techniques. Edinburgh, Churchill Livingston, p.21.
- Banacerraf B, Unanue E (1979): Textbook of Immunology. p.21.
- Bloksma N, Schmiermann P, De-Reuver M, Van-Dijk H, Willers J (1982): Stimulation of humoral and cellular immunity by viscum preparations. Planta Med 46: 221–227.
- Deshpande R, Adhikary P, Tipnis H (1974): Stored grain pest control agents from Nigella sativa and pogostemon heyneanus. Bull Grain Techno112: 232–234.
- El-Dakhakhny M (1965): Egyptian Nigella sativa. Arzneim Forsch 15: 1227–1229.
- El Tahir KE, Ashour MM, Al-Harbi MM (1993a): The respi-ratory effects of the volatile oil of the black seed (Nigella sativa) in guinea pigs: elucidation of the mechanism(s) of action. Gen Pharmacol 34: 1123–1131.
- El Tahir KE, Ashour MM, Al-Harbi MM (1993b): The car-diovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen Pharmacol 24: 1115–1122.
- Hailat N, Bataineh Z, Lafi S, Raweily E, Agel M, Al-katib M, Hanash S (1995): Effect of Nigella sativa volatile oil on Jurkat T cell leukemia polypeptides. Int J Pharmacog 33: 16–20.
- Hailat N, Keim D, Melheim R, Zhu X, Echerson C, Bor Deur G, Reynolds P, Seeger R, Lottspeich F, Strahler J, Hanash S (1991): High levels of P19/nm23 protein in neuroblas-toma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88: 341–345.
- Hailat H, Strahler J, Melhem R, Zhu X, Brodeur G, Seeger C, Reynolds P, Hanash S (1990): N-myc gene amplification in neuroblastoma is associated with altered phosphoryla-tion of a proliferation related polypeptide (0P18). Onco-gene 5: 1615–1618.
- Houghton PJ, Zarka R, de las Heras B, Hoult JR (1995): Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61: 33–36.
- Imai S, Sugiura M, Mizuno F, Ohigashi H, Koshimizu K, Chiba S, Osato T (1994): African Burkitt's lymphoma: a plant, Euphorbia tirucalli, reduces Epstein Barr virus-spe-cific cellular immunity. Anticancer Res 14: 933–936.
- Keim D, Hailat N, Hodge D, Hanash S (1990): Proliferating cell nuclear antigen expression in childhood acute leukemia. Blood 76: 985–990.
- Keshri G, Singh MM, Lakshmi V, Kamboj VP (1995): Post-coital contraceptive efficacy of the seeds of Nigella sativa in rats. Indian J Physiol Pharmacol 39: 59–62.
- Mahfous M, El-Dakhakhny M (1966): The isolation of a crystalline active principle from Nigella sativa seed. Pharm Sci United Arab Rep 1: 9–19.
- Mahfous M, El-Dakhakhny H, Gemei A, Moussa H (1962): Choleretic action of Nigella sativa seeds oil. Egyptian Pharm Bull 44: 225–229.
- Merril C, Goldman D, Sedman S, Ebert M (1981): Ultrasen-sitive stain for proteins in polyacrylamide gels show regional variation in cerebrospinal fluid. Science 211: 1437–1438.
- Nad P, Biresova M, Legat J (1995): The effects of feeding emissions from a metal-producing plant upon the immune system of sheep. Vet Med (Praha) 40: 101–104.
- Roesler J, Steinmuller C, Kiderlen A, Emmendorffer A, Wag-ner H, Lohmann-Mathes ML (1991): Application of puri-fied polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and can-dida albicans. Int J Immunopharmacol 13: 27–37.
- Toppozada H, Mazloum H, El-Dakhakhny M (1965): The antibacterial properties of Nigella Sativa seed. J Egypt Med Assoc 48: 187–202.
- Weissman IL (1975): Development and distribution of immunoglobulin-bearing cells in mice. Transplant Rev 24: 159–163.